Humana Inc. (HUM) — Analyst outlook / Analyst consensus target is. Based on 44 analyst ratings, the consensus is bullish — 13 Buy, 29 Hold, 2 Sell.
The consensus price target is $235.00 (low: $146.00, high: $345.00), representing an upside of 19.8% from the current price $196.21.
Analysts estimate Earnings Per Share (EPS) of $16.12 and revenue of $117.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $10.01 vs est $16.12 (missed -37.9%). 2025: actual $9.87 vs est $17.09 (missed -42.2%). Analyst accuracy: 33%.
HUM Stock — 12-Month Price Forecast
$235.00
▲ +19.77% Upside
Average Price Target
Based on 44 Wall Street analysts offering 12-month price targets for Humana Inc., the average price target is $235.00, with a high forecast of $345.00, and a low forecast of $146.00.
The average price target represents a +19.77% change from the last price of $196.21.
Highest Price Target
$345.00
Average Price Target
$235.00
Lowest Price Target
$146.00
HUM Analyst Ratings
Hold
Based on 44 analysts giving stock ratings to Humana Inc. in the past 3 months
EPS Estimates — HUM
33%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $10.01
vs Est $16.12
▼ 61.0% off
2025
Actual $9.87
vs Est $17.09
▼ 73.1% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — HUM
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $117.761B
vs Est $117.011B
▲ 0.6% off
2025
Actual $129.664B
vs Est $129.179B
▲ 0.4% off
Revenue Trend
Moderate revenue growth trend. Analysts expect stable revenue going forward.
